Continuous Monitoring of Pulmonary Artery Pressure Via an Implanted
2016 Continuous monitoring of pulmonary artery pres- sure via an implanted leadless and battery less pres- sure sensor for the management of patients with moderate to severe heart failure (New York Heart As- sociation class III) A single technology assessment Title Continuous monitoring of pulmonary artery pressure via an implanted leadless and battery less pressure sensor for the management of patients with moderate to severe heart failure (New York Heart Association class III). A single technology assessment. Norwegian title Kontinuerlig monitorering av trykk i pulmonalarterien via en implantert trådløs sensor uten batteri for håndtering av pasienter med moderat til alvorlig hjertesvikt (New York Heart Association class III). Hurtigmetodevurdering. Institution Norwegian Institute of Public Health (Folkehelseinstitutttet) Camilla Stoltenberg, Director Authors Pike, Eva, (Project leader), senior researcher Bjerkan, Anne Mette, senior researcher Fagerlund, Beate Charlotte, health economist Hamidi, Vida, health economist Harboe, Ingrid, research librarian Klemp, Marianne, research director, Norwegian institute of public health ISBN 978-82-8082-771-5 Type of report A single technology assessment (Hurtigmetodevurdering) No. of pages 52, 72 including appendices) Client The Ordering Forum (Bestillerforum RHF) Subject heading Heart Failure; Blood Pressure Monitoring; Ambulatory; (MeSH) Wireless Technology Citation Pike E, Bjerkan AM, Fagerlund BC, Hamidi V, Harboe I, Klemp M. Continuous monitoring of pulmonary artery pressure via an implanted leadless and battery less pressure sensor for the management of patients with moderate to severe heart failure (New York Heart Association class III). A single technology assessment from Norwegian Institute of Public Health (Folkehelseinstitutttet). Oslo: Norwegian Institute of Public Health, 2016. Norwegian Institute of Public Health Oslo, October 2016 1 Executive summary Executive summary Background In Norway the prevalence of chronic heart failure has been estimated to be 2 per- cent, meaning 80 000 – 100 000 people.
[Show full text]